| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/10/2002 | EP1194140A1 Pharmaceutical composition containing fenofibrate and preparation method |
| 04/10/2002 | EP1194138A1 Nutritional supplements |
| 04/10/2002 | EP1194136A1 Non-solid composition for local application |
| 04/10/2002 | EP1194134A1 Transdermal therapeutic system for the utilization of tolterodine |
| 04/10/2002 | EP1194133A2 Multilayered film containing an active substance and made of cross-linked hydrophilic polymers |
| 04/10/2002 | EP1194132A2 Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof |
| 04/10/2002 | EP1194131A1 Pharmaceutical dosage forms for controlled release producing at least a timed pulse |
| 04/10/2002 | EP1194130A1 Improvements in and relating to delivery capsules |
| 04/10/2002 | EP1194129A1 Self-emulsifying systems containing anticancer medicament |
| 04/10/2002 | EP1194128A2 Ionically formulated biomolecule microcarriers |
| 04/10/2002 | EP1194127A2 Method for producing powdery particle-reduced formulations with the aid of compressed gases |
| 04/10/2002 | EP1194126A1 Dry powder compositions |
| 04/10/2002 | EP1194125A1 Method for making granules with masked taste and instant release of the active particle |
| 04/10/2002 | EP1194124A1 Taste masked compositions |
| 04/10/2002 | EP1194123A2 Method for controlled production of ultrafine microparticles and nanoparticles |
| 04/10/2002 | EP1194122A1 Methods for preparation of lipid-encapsulated therapeutic agents |
| 04/10/2002 | EP1194121A1 Steroid solution aerosol products with enhanced chemical stability |
| 04/10/2002 | EP1194120A1 Clear oil-containing pharmaceutical compositions |
| 04/10/2002 | EP1194119A1 Controlled release of therapeutics by in-situ entrapment by matrix cross-linking |
| 04/10/2002 | EP1194113A2 Preservatives for perishable preparations, in particular for cosmetic and pharmaceutical preparations |
| 04/10/2002 | EP1194109A1 Topical formulations comprising skin penetration agents and the use thereof |
| 04/10/2002 | EP1128818A4 Functionalized nanocrystals and their use in detection systems |
| 04/10/2002 | EP1089719B1 Transdermal therapeutic system containing hormones and crystallization inhibitors |
| 04/10/2002 | EP1087986B1 7.alpha.-methyl 19-nortestosterone undecanoate with androgenic activity |
| 04/10/2002 | EP1051159B1 Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis |
| 04/10/2002 | EP1021172B1 Dosage form for aerosol administration |
| 04/10/2002 | EP0935458B1 Compositions containing at least one nucleic acid |
| 04/10/2002 | EP0918510B1 Bioadhesive complexes of polycarbophil and azole antifungal or antiprotozoal drugs |
| 04/10/2002 | EP0861067B1 Unit galenical form for local hormonotherapy of vaginal dryness |
| 04/10/2002 | EP0841965B1 Patch and controller for the photodynamic therapy of a dermal lesion |
| 04/10/2002 | EP0833642B1 Compressed dry-granulation desogestrel tablets |
| 04/10/2002 | EP0833618B1 Solid pharmaceutical form for oral use |
| 04/10/2002 | EP0830106B1 Tissue loading system for implantable biological devices |
| 04/10/2002 | EP0819009B1 Ovulation triggering drugs comprising luteinising hormone |
| 04/10/2002 | EP0807434B1 Anti-inflammatory eyedrops |
| 04/10/2002 | EP0788383B1 Modulation of cell proliferation and wound healing |
| 04/10/2002 | EP0771191B1 Immunological activity of rhamnolipids |
| 04/10/2002 | EP0764032B1 Stable gel formulation for topical treatment of skin conditions |
| 04/10/2002 | EP0764016B1 Use of polymers as film-forming barrier materials |
| 04/10/2002 | EP0758900B1 Botulinum toxin FOR REDUCTION OF migraine HEADACHE PAIN |
| 04/10/2002 | EP0701437B1 Multiparticulate pulsatile drug delivery system |
| 04/10/2002 | EP0680339B1 Ectoparasiticidal formulation |
| 04/10/2002 | CN2484952Y Medicinal pad for hemorrhoid |
| 04/10/2002 | CN2484951Y Compound plaster for appendicitis |
| 04/10/2002 | CN2484950Y Medical paste for pneumonia |
| 04/10/2002 | CN1344287A Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 04/10/2002 | CN1344168A Ophthalmic compsns. |
| 04/10/2002 | CN1344166A Use of enterobacterium protein ompA associated with antigen for generating antiviral, antiparasitic or antitumoral cytotoxic response |
| 04/10/2002 | CN1344165A Antiviral agent in form of nose drops |
| 04/10/2002 | CN1344163A Stabilized oral pharmaceutical compsn. contg. iodide and iodate and method |
| 04/10/2002 | CN1344156A Compsns. and method for improving integrity of compromised body passageways and cavities |
| 04/10/2002 | CN1344155A Transnasal transport/immunisation with highly adaptable carriers |
| 04/10/2002 | CN1344154A Absorbent article compsn. and method of use for sequestering skin irritants |
| 04/10/2002 | CN1344153A Facial tissue compsn. and method of use for sequestration of nasal secretion skin irritants |
| 04/10/2002 | CN1344152A Resorcinol compsn. |
| 04/10/2002 | CN1344145A Method for producing cometic or pharmaceutical formulations by means of micromixture directly before use |
| 04/10/2002 | CN1343522A Radioactive macroaggregate and its prepn. method |
| 04/10/2002 | CN1343521A Preparing box for polysaccharide compounding substance |
| 04/10/2002 | CN1343520A Method for controlling slow release speed of medicine by porous nano carrier material |
| 04/10/2002 | CN1343518A Efficacy and application of soft capsule or oily pill prepared by mixing tomato seed oil with rubin |
| 04/10/2002 | CN1343512A Process for preparing vasculitis medicine |
| 04/10/2002 | CN1343508A Chinese patent medicine for treating peptic ulcer |
| 04/10/2002 | CN1343507A 'Pingweisu' capsule for treating gastric disease |
| 04/10/2002 | CN1343489A Percutaneous absorption type anticancer medicine to suppress hyperplasia and untoward differentiation of cells |
| 04/10/2002 | CN1343488A Capsule and its preparing process and application |
| 04/10/2002 | CN1082379C Paste for treating aphtha and its prepn. method |
| 04/10/2002 | CN1082372C Liquid medicine for treating bromidrosis, and its prepn. method |
| 04/10/2002 | CN1082369C Formulations contg. carotenoids and procarotenoids combined with polyphenols |
| 04/10/2002 | CN1082366C 气溶胶制剂 Aerosol formulation |
| 04/09/2002 | US6369217 Scleroglucans and cosmetic compositions containing the new compounds |
| 04/09/2002 | US6369126 Adhesive for secure topical attachment to the skin and comfortable removal |
| 04/09/2002 | US6369116 Composition and method for treating glaucoma |
| 04/09/2002 | US6369115 Stabilized powder formulations |
| 04/09/2002 | US6369113 Antidepressants, parkinson's disease |
| 04/09/2002 | US6369094 3-(n-methyl-2(r)-pyrrolidinylmethyl)-5-(2-phenylsulphonylethyl )-1h-indole, analgesic for migrane |
| 04/09/2002 | US6369087 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| 04/09/2002 | US6369062 Sustained release ranolazine formulations |
| 04/09/2002 | US6369046 Administration of a glucocorticoid receptor antagonist, mifepristone |
| 04/09/2002 | US6369037 Impregnated in a dextran-methacrylate biodegradable hydrogel; higher cumulative release in acid ph (e.g., the stomach); prepared without chemical crosslinker and heat; oral administration or an implant |
| 04/09/2002 | US6368788 Method of treating complications in immunodepressed states resulting from HIV infection |
| 04/09/2002 | US6368638 Neutralization of stomach acid |
| 04/09/2002 | US6368635 Gastrointestinal mucosa-adherent matrixes pharmaceutical preparations and a coating composition |
| 04/09/2002 | US6368634 High release solid preparation, preparation and use thereof |
| 04/09/2002 | US6368633 Microparticles which controllably release olfactorily active substances, methods of using same and processes for preparing same |
| 04/09/2002 | US6368632 Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
| 04/09/2002 | US6368631 Fine grain carriers and medicinal composition prepared with the use of the same |
| 04/09/2002 | US6368630 Modulated release from biocompatible polymers |
| 04/09/2002 | US6368629 Drug with protective coatings |
| 04/09/2002 | US6368628 Multilayer |
| 04/09/2002 | US6368627 Compositions |
| 04/09/2002 | US6368626 Semipermeable wall |
| 04/09/2002 | US6368625 Dosage forms |
| 04/09/2002 | US6368624 Homogenizing, cooling leaves, freeze drying |
| 04/09/2002 | US6368622 Process for preparing solid formulations of lipid regulating agents with enhanced dissolution and absorption |
| 04/09/2002 | US6368621 Preparation in particular for use as a medication and/or food supplement |
| 04/09/2002 | US6368620 Antilipemic agent |
| 04/09/2002 | US6368619 Hydrophobic preparations of hydrophilic species and process for their preparation |
| 04/09/2002 | US6368616 Aqueous suspension for nasal administration of loteprednol |
| 04/09/2002 | US6368615 Polymer of unsaturated ester of salicylic acid |
| 04/09/2002 | US6368613 Antiinflammatory agents; in situ administering |